**Dear Editor:**

The original paper by Molaeipoor et al. \[[@b1-epih-37-e2015007]\] has come at just the right time. While the availability of highly active antiretroviral therapy (HAART) has come as a boon for the human immunodeficiency virus (HIV)-infected population and is instrumental in prolonging life and improving its quality, the co-morbidities associated with HIV remain as a cause for concern. A previous study has noted that HIV-seropositive patients have significantly higher chances of developing other infections like tuberculosis (TB) \[[@b2-epih-37-e2015007]\]. The HIV disease course is influenced by the presence of co-morbidities that include infectious diseases like TB, hepatitis B, hepatitis C, and other infectious and non-infectious conditions including malignancies \[[@b3-epih-37-e2015007],[@b4-epih-37-e2015007]\]. A recent study has also observed that the disease burden in HIV patients is significantly related to illicit drug use \[[@b5-epih-37-e2015007]\]. It must be noted that identification of various co-morbidities and their underlying causes prior to initiation of HAART is necessary to minimise related additional complications and resultant morbidity and mortality. The results of Molaeipoor et al. \[[@b1-epih-37-e2015007]\] indicating that overcrowding (e.g., in jails), adverse effects of HAART, prior latent TB infection, TCD4^+^ counts lower than 350 cells/mm^3^, and prophylactic therapy against other infections were more instrumental in predisposing HIV-seropositive patients to TB than was drug abuse are very significant findings. These results further suggest that future research should concentrate on nutritional issues (e.g., malnutrition) in the HIV-infected population, which may include vitamin and mineral deficiencies.
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